Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals.
It is. my pleasure to invite you to join me August 22-23, 2014 in sunny Dana Point, California for the inaugural US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes 2014. This meeting promises to be a first-class educational event that focuses on the latest advances in MDS and MPN.
This conference will provide a platform to resolve many of the clinical challenges for diagnosis and treatment through presentations and interactive discussions of the latest clinical and research findings pertaining to MPNs and MDS. Topics that will be deliberated by recognized experts in the field during this congress include the underlying biology of MPNs and MDS, and how these events impact clinical practice including updates in therapeutic interventions of MDS, polycythemia vera, essential thrombocytopenia and myelofibrosis. Advancements in classification and diagnosis of disease and how these contribute to more robust risk stratification along with the identification of novel therapies will also be discussed in the context of optimizing clinical outcomes and enhancing patient quality of life.
With few other meetings of this type currently in the United States, this highly-relevant clinical conference will provide the basis to advance understanding, optimize therapy and patient outcomes for MPNs and MDS. The US Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes 2014 will bring to the United States the same outstanding, clinically-relevant knowledge pertaining to MPNs and MDS that has been provided to the European medical community through its sister conference.
We look forward to seeing you in August, for what is sure to be an educational and informative scientific meeting.Sincerely,
Srdan Verstovsek, MD, PhD
|Early Registration Deadline||June 26, 2014|
|Discounted Registration Deadline||August 14, 2014|
||August 22-23, 2014|